STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

<iframe
  src="https://statesidedaily.com/embed/cluster/ea901de5d18e500b6afcc857095d9ed8c7ad3c11"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching"></iframe>